Core Insights - He Eye Hospital has signed a comprehensive strategic cooperation agreement with Johnson & Johnson Vision Care, aiming to enhance cataract diagnosis and treatment technology, dry eye treatment services, and talent development by 2026 [1][2] - This partnership is a significant step for He Eye Hospital in implementing its "Smart Light City" strategy, leveraging global resources for high-quality development and innovation in the ophthalmology industry [1] Group 1 - The collaboration will focus on the clinical application and promotion of new ophthalmic technologies and products in the Chinese market, including advanced devices such as the Smart Preloaded Intraocular Lens and Catalys 7.0 Femtosecond Laser Treatment System [2] - He Eye Hospital aims to establish a comprehensive multidisciplinary diagnosis and treatment system for presbyopia through the joint efforts with Johnson & Johnson Vision Care [2] - The partnership will integrate Johnson & Johnson's global vision and innovation capabilities with He Eye Hospital's clinical resources and research platforms, enhancing the quality of patient care [2] Group 2 - He Eye Hospital has established a solid foundation for this strategic cooperation through its platforms, including the International Ophthalmology Foundation and the National Clinical Trial Institution [2] - The agreement will facilitate the introduction of innovative products and medical management concepts in the fields of gene therapy, stem cells, artificial intelligence, and biomedicine [1][2] - The collaboration is expected to create a digital platform that encompasses the entire lifecycle of eye health management and consumer consultation services [1]

Core Insights - He Eye Hospital Group signed a comprehensive strategic cooperation agreement with Johnson & Johnson Vision Care during the 8th China International Import Expo, aiming to advance clinical application of new ophthalmic technologies and products [2][3] Group 1: Strategic Cooperation - The agreement focuses on collaboration in cataract treatment technology, promotion of advanced medical equipment, development of presbyopia solutions, enhancement of clinical capabilities, and training of young and middle-aged surgeons [2][3] - Both parties will accelerate the application and promotion of innovative ophthalmic products and technologies in the Chinese market, including the Smart Preloaded Intraocular Lens, Catalys 7.0 femtosecond laser treatment machine, Veritas ultrasound phacoemulsification device, and Elita femtosecond laser corneal refractive surgery equipment [2] Group 2: Goals and Vision - The partnership aims to establish a comprehensive multidisciplinary treatment system for presbyopia, enhancing patient visual quality and integrated treatment solutions, thereby setting industry benchmarks [2] - He Eye Hospital, as a technology-driven listed entity, seeks to leverage global resources for high-quality development, aligning with its "Smart Bright City" strategy [3] - The collaboration is expected to provide an innovative model for the development and service upgrade of the Chinese ophthalmic industry, benefiting the public through technological advancements [3]

Core Viewpoint - The strategic cooperation agreement between He Eye Hospital and Johnson & Johnson Vision Care aims to enhance cataract diagnosis and treatment technologies, dry eye services, and talent development in the ophthalmology field [1][2]. Group 1: Strategic Cooperation - He Eye Hospital and Johnson & Johnson Vision Care will collaborate on advancing clinical applications of new ophthalmic technologies and products, focusing on cataract treatment, advanced medical equipment promotion, presbyopia development, and clinical skill enhancement for young and mid-career doctors [1]. - The partnership will accelerate the introduction of innovative ophthalmic products and technologies in the Chinese market, including the Smart Preloaded Intraocular Lens, Catalys 7.0 femtosecond laser treatment machine, Veritas ultrasound emulsification device, and Elita femtosecond laser corneal refractive surgery equipment [1]. Group 2: Goals and Vision - The collaboration is expected to drive the Chinese refractive cataract surgery into a new era of intelligence, providing patients with a globally advanced treatment experience and contributing to the long-term development of eye health under the "Healthy China" strategy [2]. - The partnership will leverage Johnson & Johnson Vision Care's global perspective, innovation capabilities, and talent development experience to promote cutting-edge ophthalmic technologies, high-end equipment, and personalized services widely in China [2].